Cheng Kunming, Di Hui, Wu Chunchun, Zhao Hongjie, Li Wanqing
Department of Intensive Care Unit, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Department of Plastic Surgery, Affiliated Hospital of Hebei University, Baoding, China.
Ann Surg Oncol. 2025 Apr 23. doi: 10.1245/s10434-025-17336-3.
Breast cancer, one of the most prevalent malignancies affecting women, poses significant treatment challenges due to the presence of breast cancer stem cells (BCSCs), which may contribute to treatment resistance, recurrence, and metastasis. Targeting BCSCs is increasingly seen as a promising therapeutic approach and a series of BCSC-related studies have been published recently. Nevertheless, no study has yet employed bibliometric analysis to examine the overall landscape of BCSC research.
All BCSC-related papers published between 1998 and 2023 were extracted from Web of Science Core Collection database. Bibliometric analysis was conducted by using VOSviewer, CiteSpace, and two online platforms.
A sum of 1771 papers including 1502 research articles and 269 review papers were ultimately included. The annual number of papers related to BCSCs has increased with the year, and the average annual growth rate during 1998 and 2023 was 18.4%. China and the USA undoubtedly dominate on a global scale, accounting for more than three-fifths of all publications. The University of Michigan System has published the most papers in this area. On the basis of the results from highly cited studies and high-frequency keywords, the research hotspots of BCSCs currently focus on domains including stemness and membrane biomarkers, key signaling pathways and molecules, therapeutic targeting and plasticity, therapeutic resistance, tumor characteristics, and microenvironment. In addition, the findings from keywords co-occurrence and burst analysis implied that research areas such as ferroptosis, GLI1, molecular docking, glycolysis, tumor microenvironment, copper, RUNX2, hyaluronic acid, cytokines, NANGO, long non-coding RNAs, triple-negative breast cancer, nanoparticles, Hippo pathway, and T cells warrant ongoing attention in the future. Additionally, TGFB1, STAT3, MYC, GAPDH, and INS were identified as the top five genes receiving the highest research focus within BCSC studies.
This is the first study to comprehensively map the current state and global emerging trends in BCSC research through a bibliometric analysis. These findings provide a comprehensive overview of BCSC research and may serve as a useful reference for scholars and policymakers to identify emerging trends and prioritize future research directions in this field.
乳腺癌是影响女性的最常见恶性肿瘤之一,由于乳腺癌干细胞(BCSCs)的存在,给治疗带来了重大挑战,这些干细胞可能导致治疗耐药、复发和转移。靶向BCSCs越来越被视为一种有前景的治疗方法,最近已经发表了一系列与BCSCs相关的研究。然而,尚未有研究采用文献计量分析来审视BCSCs研究的整体情况。
从Web of Science核心合集数据库中提取1998年至2023年间发表的所有与BCSCs相关的论文。使用VOSviewer、CiteSpace和两个在线平台进行文献计量分析。
最终纳入了1771篇论文,其中包括1502篇研究文章和269篇综述论文。与BCSCs相关的论文数量逐年增加,1998年至2023年期间的年均增长率为18.4%。中国和美国在全球范围内无疑占据主导地位,占所有出版物的五分之三以上。密歇根大学系统在该领域发表的论文最多。基于高被引研究和高频关键词的结果,BCSCs目前的研究热点集中在干性和膜生物标志物、关键信号通路和分子、治疗靶向和可塑性、治疗耐药性、肿瘤特征以及微环境等领域。此外,关键词共现和爆发分析的结果表明,铁死亡、GLI1、分子对接、糖酵解、肿瘤微环境、铜、RUNX2、透明质酸、细胞因子、NANGO、长链非编码RNA、三阴性乳腺癌、纳米颗粒、Hippo通路和T细胞等研究领域在未来值得持续关注。此外,TGFB1、STAT3、MYC、GAPDH和INS被确定为BCSCs研究中受到最高研究关注的前五个基因。
这是第一项通过文献计量分析全面描绘BCSCs研究现状和全球新兴趋势的研究。这些发现提供了BCSCs研究的全面概述,可为学者和政策制定者识别新兴趋势以及确定该领域未来研究方向的优先级提供有用参考。